X4 Pharmaceuticals (XFOR) Exchange Rate Effect (2017 - 2025)
X4 Pharmaceuticals (XFOR) posted Exchange Rate Effect of $3000.0 for Q4 2025, up 400.0% on a QoQ basis from -$1000.0 in Q3 2025, and up 101.23% year-over-year from $1490.8 in Q4 2024.
X4 Pharmaceuticals (XFOR) Exchange Rate Effect (2017 - 2025) Analysis & Trends
X4 Pharmaceuticals' Exchange Rate Effect history runs 9 years deep, the most recent figure standing at $3000.0 for Q4 2025.
- Quarterly Exchange Rate Effect rose 101.23% year-over-year to $3000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $213000.0 (up 236.54% YoY) and the FY2025 annual result came in at $213000.0, up 236.54% from the prior year.
- Exchange Rate Effect was $3000.0 for Q4 2025 at X4 Pharmaceuticals, up from -$1000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $363000.0 in Q4 2022 and bottomed at -$244000.0 in Q4 2024.
- A 5-year average of -$13400.0 and a median of -$12000.0 in 2023 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect tumbled 605.0% — and 2025, when it soared 872.22%.
- X4 Pharmaceuticals' Exchange Rate Effect stood at -$116000.0 in 2021, then jumped by 412.93% to $363000.0 in 2022, then plunged by 65.01% to $127000.0 in 2023, then tumbled by 292.13% to -$244000.0 in 2024, then surged by 101.23% to $3000.0 in 2025.
- Business Quant data shows XFOR's Exchange Rate Effect at $3000.0 in Q4 2025, -$1000.0 in Q3 2025, and $139000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 472.06 Bn | 467.27 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 122.10 Bn | 114.85 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.25 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.75 Bn | 50.57 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.50 Bn | 959.66 Mn | -7.06 Mn |
| 10 | X4 Pharmaceuticals | 167.90 Mn | -49.15 Mn | 2.20 Mn | 3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Dec 31, 2024 | -244,000.00 |
| Dec 31, 2024 | -244,000.00 |
| Sep 30, 2024 | 165,000.00 |
| Sep 30, 2024 | 165,000.00 |
| Jun 30, 2024 | -18,000.00 |
| Jun 30, 2024 | -18,000.00 |
| Mar 31, 2024 | -59,000.00 |
| Mar 31, 2024 | -59,000.00 |
| Dec 31, 2023 | 127,000.00 |
| Dec 31, 2023 | 127,000.00 |
| Sep 30, 2023 | -72,000.00 |
| Sep 30, 2023 | -72,000.00 |